Patient Satisfaction Using Guselkumab Self-administered Using the One-Press Device for Treatment of Moderate-to-Severe Psoriasis: Results from a National, Prospective, Real-World Study in Portugal (CERES Study).

Dermatol Ther (Heidelb) · 2026 · PMC13013721 · PMID 41665798

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantp < 0.001actually significant

The Confidence (CO) domain showed a substantial improvement from a mean of 6.3 ± 2.7 to 7.5 ± 2.4, and the Satisfaction (SA) domain increased markedly from 6.5 ± 2.9 to 8.9 ± 1.6, both with highly significant p -values ( p < 0.001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.